Rad Onc Resource simgesi

1.8 by ADF Android Development


Aug 19, 2015

Rad Onc Resource hakkında

Türkiye

This application is intended for use by practitioners of radiation oncology.

Rad Onc Resource is an application intended for use by practitioners of radiation oncology. It is useful in the clinic and also for radiation treatment planning.

This version contains six features:

-Tissue Tolerance: Gives estimates of normal tissue tolerance for conventional and hypofractionated radiotherapy

-B.E.D. Calculator: Calculates biologic equivalence of different dose/fractionation schemes using the linear quadratic model

-Breast Cancer Recurrence Risk Estimator: Estimates risk of any recurrence after BCT for pN0 patients based on the EBCTCG data

-Rad Onc Wiki: Link to a very useful online evidence-based resource for radiation oncology.

-Prostate Cancer: Risk of pathologic stage based on Gleason, PSA, and Clinical Stage, as well as NCCN recommended workup

-Schonberg Index: A scientifically validated estimate of 5 year and 9 year mortality based on an 11 question survey for elderly patients.

Future versions of this application will include additional features, based on user feedback.

En son sürümde yeni olan 1.8

Last updated on Aug 19, 2015

Version 1.8:

-Added social networking feature. Allows users to chat, message one another, and link to twitter
-Log in using e-mail or twitter account
-Facebook integration currently NOT available

Çeviri Yükleniyor...

Ek UYGULAMA Bilgileri

En Son Sürüm

Güncelleme Rad Onc Resource İste 1.8

Yükleyen

Daniel Carranza

Gereken Android sürümü

Android 2.2+

Daha Fazla Göster

Rad Onc Resource Ekran görüntüleri

Yorum Yükleniyor...
Diller
Diller
Aranıyor...
APKPure'a abone olun
En iyi Android oyunlarının ve uygulamalarının ilk sürümüne, haberlerine ve rehberlerine ilk erişen kişi olun.
Hayır, teşekkürler
Üye olmak
Başarıyla abone oldu!
Şimdi APKPure'ye abone oldunuz.
APKPure'a abone olun
En iyi Android oyunlarının ve uygulamalarının ilk sürümüne, haberlerine ve rehberlerine ilk erişen kişi olun.
Hayır, teşekkürler
Üye olmak
Başarı!
Şimdi bültenimize abone oldunuz.